Business Context and Reporting Period
This Form 6-K filing by InflaRx N.V. is dated January 22, 2018. The company, headquartered in Jena, Germany, filed this report to disclose the convening of an extraordinary general meeting of shareholders scheduled for February 6, 2018.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notice of a corporate meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The primary event is the administrative action of notifying shareholders of the upcoming extraordinary general meeting.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It references attached exhibits (Convening notice and Voting proxy) which contain the agenda and explanatory notes for the meeting, but the content of those exhibits is not detailed in the main text of this summary.
Key Facts for Investors
- Meeting Date: An extraordinary general meeting of shareholders is scheduled for February 6, 2018.
- Document Purpose: This filing provides the convening notice, agenda, and voting proxy materials to shareholders.
- Financial Data: No financial results or metrics are included in this specific filing.
- Signatory: The report was signed by Niels Riedemann, Chief Executive Officer.